MT-304

· Myeloid Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MT-304, covering 2026-02-19 to 2026-02-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors [Phase 1]

See pricing